[{"Assets_0_Q2_USD":"733997000.0","CIK":"1737287","CommonStockSharesIssued_0_Q2_shares":"121631278.0","CommonStockSharesOutstanding_0_Q2_shares":"121631278.0","Country":"United States","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-55148000.0","NetIncomeLoss_1_Q2_USD":"-41243000.0","NetIncomeLoss_2_Q2_USD":"-72829000.0","OfficialName":"Allogene Therapeutics Inc. Common Stock","ProfitLoss_2_Q2_USD":"-72829000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"655635000.0","Ticker":"ALLO","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":"99846946.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":"98588410.0","filed":"20190807","footnote":null,"form":"10-Q","fp":"Q2","fy":"2019.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20190630","qtrs":"0","uom":"USD"}]